Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blinded and Placebo-Controlled Trial to Assess the Impact of Biophoton Therapy on Self-Grown Stem Cells

NCT06855459 is registered in ClinicalTrials.gov with First Institute of All Medicines as lead sponsor.

NCT NCT06855459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06855459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blinded and Placebo-Controlled Trial to Assess the Impact of Biophoton Therapy on Self-Grown Stem Cells
Lead sponsor
First Institute of All Medicines
Phase
Not applicable
Overall status
Completed
Start date
February 10, 2025
Completion date
April 30, 2026
Enrollment
71 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

increase the total number of stem cells, inflammation